Overview
Hemocholecyst, likely a typographical error and possibly referring to a condition involving both hepatic and vascular complications, is not directly addressed in the provided abstracts. However, the context seems to relate to disseminated intravascular coagulation (DIC) associated with aortic endoleaks post-endovascular aneurysm repair, particularly in patients with underlying risk factors like thrombocytopenia or cirrhosis 1.Diagnosis
Chronic thrombocytopenia prior to endoleak development 1
Evidence of persistent high-flow endoleak (type Ia or III) 1
Laboratory findings indicative of disseminated intravascular coagulation (DIC) such as prolonged PT/aPTT, low fibrinogen, elevated D-dimer 1
Imaging confirmation of aortic endoleak 1Management
Surgical Repair: Recommended for patients with refractory or severe endoleaks 1
Medical Management: Considered for patients unsuitable for surgery, focusing on supportive care and anticoagulation as needed 1
Anticoagulation: Specific drug classes and doses not detailed; tailored to DIC management principles 1Special Populations
Comorbidities: Thrombocytopenia identified as a risk factor for DIC development post-endoleak 1
Cirrhosis: Previously reported as a risk factor, though not the focus of the current cases 1Key Recommendations
Consider chronic thrombocytopenia as a risk factor for developing DIC secondary to aortic endoleaks post-endovascular aneurysm repair (Evidence: Moderate) 1
Evaluate surgical intervention for definitive management of persistent high-flow endoleaks in patients with severe or refractory DIC (Evidence: Weak) 1
For medically managed patients, implement supportive care measures tailored to DIC, including appropriate anticoagulation (Evidence: Expert opinion) 1References
1 Nienaber JJ, Duncan AA, Oderich GS, Pruthi RK, Nichols WL. Operative and nonoperative management of chronic disseminated intravascular coagulation due to persistent aortic endoleak. Journal of vascular surgery 2014. link